Measuring the concerns of cancer patients with low platelet counts: The Functional Assessment of Cancer Therapy-Thrombocytopenia (FACT-Th) questionnaire

Supportive Care in Cancer

Volumn 14, Issue 12, 2006, Pages 1220-1231

  Cella, David ^a   Beaumont, Jennifer L ^a   Webster, Kimberly A ^a   Lai, Jin Shei ^a   Elting, Linda ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

FACT; Patient reported outcome; Platelets; Quality of life; Thrombocytopenia

Indexed keywords

ADULT; AGED; ARTICLE; CANCER; CANCER PATIENT; EVALUATION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT OF CANCER THERAPY THROMBOCYTOPENIA QUESTIONNAIRE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MOOD; PERCEPTION; PERFORMANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SCORING SYSTEM; SELF REPORT; SOCIAL DESIRABILITY; SYMPTOM; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VALIDATION PROCESS; VALIDITY; WELLBEING;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT COMPLIANCE; PLATELET COUNT; QUALITY OF LIFE; QUESTIONNAIRES; THROMBOCYTOPENIA;

EID: 33751265244     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-006-0102-1     Document Type: Article

References (28)

1. Bastion Y, Blay J, Divine M, Brice P, Bordessoule D, Sebban C, Blanc M, Tilly H, Lederlin P, Deconinck E, Salles B, Dumontet C, Briere J, Coiffier B (1997) Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival-a Groupe D'Etude Des Lymphomes De L'Adulte study on 453 patients older than 69 years. J Clin Oncol 15:2945-2953
2. Cella D (1997) Manual of the Functional Assessment of Chronic Illness Therapy (FACIT scales), version 4. Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University, Evanston, IL, USA
3. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570-579
4. Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297-334
5. Crowne DP, Marlowe D (1960) A new scale of social desirability independent of psychopathology. J Consult Psychol 24:344-354
6. Demetri GD (2001) Targeted approached for the treatment of thrombocytopenia. Oncologist 6:15-23
7. Elting LS (1999) Chemotherapy-induced thrombocytopenia and the use of prophylactic platelet transfusions and growth factors. In: 11th MASCC international symposium: supportive care in cancer, Nice, France, 18-20 February 1999
8. Elting LS, Rubenstein EB, Martin CG, Kurtin D, Rodriguez S, Laiho E, Kanesan K, Cantor SB, Benjamin R (2001) Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia. J Clin Oncol 19:1137-1146
9. Elting LS, Cantor SB, Martin CG, Hamblin L, Kurtin D, Rivera E, Vadhan-Raj S, Benjamin R (2003) Cost of chemotherapy-induced thrombocytopenia among patients with lymphoma or solid tumors. Cancer 97:1541-1550
10. Engel C, Loeffler M, Franke H, Schmitz S (1999) Endogenous thromboprotein serum levels during multicycle chemotherapy. Br J Haematol 105:832-838
11. Fraboni M, Cooper D (1989) Further validation of three short forms of the Marlowe-Crowne scale of social desirability. Psychol Rep 65:595-600
12. Goodnough LT, DiPersio JF (2002) Issues in the management of cancer-related thrombocytopenia. Oncology 16:1558-1567
13. Linacre JM (1994) Sample size and item calibration stability. Rasch Meas Trans 7:328
14. Linacre JM (2002) WINSTEPS. Chicago
15. Ludwin D, Sacks P, Lynch S, Jacobs P, Bezwoda W, Bothwell TH (1974) Auto-immune haematological complications occurring during the treatment of malignant lymphoproliferative disease. S Afr Med J 48:2143-2145
16. Malone D, Sullivan S, Black D, Stergachis A (1995) The cost of treating chemotherapy induced thrombocytopenia (in the proceedings of the American Society of Clinical Oncology). J Clin Oncol 14:305
17. McNair DM, Lorr M, Droppleman LF (1992) Profile of Mood States (POMS). Educational and Industrial Testing Service, San Diego, CA, USA
18. Meehan KR, Matias CO, Rathore SS, Sandler SG, Kallich J, LaBrecque J, Erder H, Schulman KA (2000) Platelet transfusions: utilization and associated costs in a tertiary care hospital. Am J Hematol 64:251-256
19. Nunnally JC, Bernstein IH (1994) Psychometric theory. McGraw-Hill, New York
20. Rubenstein EB, Elting L (1998) Incorporating new modalities into practice guidelines: platelet growth factors. Oncology 12:381-386
21. Rust DM, Wood LS, Battiato LA (1999) Oprelvekin: an alternative treatment for thrombocytopenia. Clin J Oncol Nurs 3:57-62
22. Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, Goldsmith M, Goldstein M, Hume H, McCullough JJ, McIntyre RE, Powell BL, Rainey JM, Rowley SD, Rebulla P, Troner MB, Wagnon AH, American Society of Clinical Oncology (2001) Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1519-1538
23. Schiller JH, Ritch PS, Storer B, Trump DL (1989) A pilot study of short-course, high-dose cytosine arabinoside, etoposide, and cisplatin in refractory, aggressive-histology, non-Hodgkin's Lymphomas. Am J Clin Oncol 12:502-506
24. Tepler I, Elias L, Smith JW, Hussein M, Rosen G, Chang AYC, Moore JO, Gordon MS, Kuca B, Beach KJ, Loewy JW, Garnick MB, Kaye JA (1996) A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 87:3607-3614
25. Ware JE, Snow KK, Kosinski M (2000) SF-36 health survey: manual and interpretation guide. QualityMetric, Lincoln, RI, USA
26. Webster K, Odom L, Peterman AH, Lent L, Cella D (1999) The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: validation of version 4 the core questionnaire. Qual Life Res 8:604
27. Wright BD, Tennant A (1996) Sample size again. Rasch Meas Trans 9:468
28. Zubrod C, Schneiderman M, Frei E III, Brindley C, Gold GL, Shnider B, Oviedo R, Gorman J, Jones R Jr, Jonsson U, Colsky J, Chalmers T, Ferguson B, Dederick M, Holland J, Selawry O, Regelson W, Lasagna L, Owens AH (1960) Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene. J Chronic Dis 11:7-33